Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in The Netherlands.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Attention-deficit hyperactivity disorder (ADHD) is the most common mental health disorder in youths. Stimulants are the drugs of first choice in the treatment of ADHD. It has been suggested that full costs associated with the treatment of ADHD may be reduced by once-daily administration regimens of stimulants.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): CNS Drugs

Title: CNS drugs

ISSN: 1172-7047

ISSN (Print): 1172-7047

Publication date (Electronic): 2008

Volume: 22

Issue: 2

Affiliations

[1 ] Groningen University Institute for Drug Exploration, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen, The Netherlands. adrianne.faber@chello.nl

Article

Publisher Item ID: 2226

PubMed ID: 18193926

SO-VID: 5e05ab3c-a646-4e65-923a-849cd70ee1d7

History

Data availability:

Comments

Comment on this article

Cited by 5

See all cited by